NAT MED 润色咨询

NATURE MEDICINE

出版年份:1995 年文章数:1683 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:0.8% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2144371, encodeId=279421443e14d, content=审稿速度:1.0<br>偏重的研究方向:临床医学<br>经验分享:4个月AIP, 6个月正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a0e5414334, createdName=ms4000001950564800, createdTime=Fri Jun 23 13:31:24 CST 2023, time=2023-06-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=538081, encodeId=e6c95380814a, content=我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=885, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baab2077197, createdName=1581f162d2m, createdTime=Fri Jun 16 00:00:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949968, encodeId=750294996859, content=想中一篇, 有没有什么捷径?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Sun Mar 21 20:18:57 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070171, encodeId=ad8d10e01712a, content=投稿命中率:5.0<br>偏重的研究方向:Medicine;医学<br>经验分享:终于发了一篇~~脑卒中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Sun Nov 14 15:33:50 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095494, encodeId=4373109549485, content=引言需要写什么内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095493, encodeId=9aef1095493ba, content=引言一般分几段?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=549, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566699, encodeId=41ff56669936, content=我以第一作者身份发过5篇,审稿三天。ps:在梦里。<span class="quote">158****9100暂无昵称 2017-06-16 发表::<br>SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span><span class="quote">158****9100 2017-06-16 00:00:00 发表:<br>我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span>, beContent=158****9100暂无昵称 2017-06-16 发表:: SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Tue Feb 12 00:00:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860086, encodeId=ab9e8600864a, content=医学权威期刊,很幸运最近接收了一篇,祝好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=774, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88545414070, createdName=ms6126899454860855, createdTime=Fri May 01 18:24:26 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558775, encodeId=33dc558e75a1, content=和cancer cell一样都是魔王级受虐刊物 要求故事完整 论据充分 并不需和正刊一样的新颖性 即便如此 还是很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1063, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 20:17:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916839, encodeId=2dda91683946, content=注重临床,必须要有临床数据,纯动物的不行。虽然是子刊,但文章的应用价值比Nature还要高,可信度也要高。是CNS里面最好的子刊了,发一篇这个不比CNS差,国内发nature medicine比CNS还难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Jan 15 10:45:56 CST 2021, time=2021-01-15, status=1, ipAttribution=)]
    2023-06-23 ms4000001950564800 来自上海

    审稿速度:1.0
    偏重的研究方向:临床医学
    经验分享:4个月AIP, 6个月正式接收

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2144371, encodeId=279421443e14d, content=审稿速度:1.0<br>偏重的研究方向:临床医学<br>经验分享:4个月AIP, 6个月正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a0e5414334, createdName=ms4000001950564800, createdTime=Fri Jun 23 13:31:24 CST 2023, time=2023-06-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=538081, encodeId=e6c95380814a, content=我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=885, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baab2077197, createdName=1581f162d2m, createdTime=Fri Jun 16 00:00:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949968, encodeId=750294996859, content=想中一篇, 有没有什么捷径?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Sun Mar 21 20:18:57 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070171, encodeId=ad8d10e01712a, content=投稿命中率:5.0<br>偏重的研究方向:Medicine;医学<br>经验分享:终于发了一篇~~脑卒中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Sun Nov 14 15:33:50 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095494, encodeId=4373109549485, content=引言需要写什么内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095493, encodeId=9aef1095493ba, content=引言一般分几段?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=549, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566699, encodeId=41ff56669936, content=我以第一作者身份发过5篇,审稿三天。ps:在梦里。<span class="quote">158****9100暂无昵称 2017-06-16 发表::<br>SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span><span class="quote">158****9100 2017-06-16 00:00:00 发表:<br>我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span>, beContent=158****9100暂无昵称 2017-06-16 发表:: SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Tue Feb 12 00:00:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860086, encodeId=ab9e8600864a, content=医学权威期刊,很幸运最近接收了一篇,祝好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=774, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88545414070, createdName=ms6126899454860855, createdTime=Fri May 01 18:24:26 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558775, encodeId=33dc558e75a1, content=和cancer cell一样都是魔王级受虐刊物 要求故事完整 论据充分 并不需和正刊一样的新颖性 即便如此 还是很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1063, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 20:17:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916839, encodeId=2dda91683946, content=注重临床,必须要有临床数据,纯动物的不行。虽然是子刊,但文章的应用价值比Nature还要高,可信度也要高。是CNS里面最好的子刊了,发一篇这个不比CNS差,国内发nature medicine比CNS还难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Jan 15 10:45:56 CST 2021, time=2021-01-15, status=1, ipAttribution=)]
    2017-06-16 1581f162d2m

    我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2144371, encodeId=279421443e14d, content=审稿速度:1.0<br>偏重的研究方向:临床医学<br>经验分享:4个月AIP, 6个月正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a0e5414334, createdName=ms4000001950564800, createdTime=Fri Jun 23 13:31:24 CST 2023, time=2023-06-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=538081, encodeId=e6c95380814a, content=我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=885, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baab2077197, createdName=1581f162d2m, createdTime=Fri Jun 16 00:00:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949968, encodeId=750294996859, content=想中一篇, 有没有什么捷径?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Sun Mar 21 20:18:57 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070171, encodeId=ad8d10e01712a, content=投稿命中率:5.0<br>偏重的研究方向:Medicine;医学<br>经验分享:终于发了一篇~~脑卒中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Sun Nov 14 15:33:50 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095494, encodeId=4373109549485, content=引言需要写什么内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095493, encodeId=9aef1095493ba, content=引言一般分几段?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=549, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566699, encodeId=41ff56669936, content=我以第一作者身份发过5篇,审稿三天。ps:在梦里。<span class="quote">158****9100暂无昵称 2017-06-16 发表::<br>SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span><span class="quote">158****9100 2017-06-16 00:00:00 发表:<br>我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span>, beContent=158****9100暂无昵称 2017-06-16 发表:: SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Tue Feb 12 00:00:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860086, encodeId=ab9e8600864a, content=医学权威期刊,很幸运最近接收了一篇,祝好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=774, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88545414070, createdName=ms6126899454860855, createdTime=Fri May 01 18:24:26 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558775, encodeId=33dc558e75a1, content=和cancer cell一样都是魔王级受虐刊物 要求故事完整 论据充分 并不需和正刊一样的新颖性 即便如此 还是很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1063, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 20:17:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916839, encodeId=2dda91683946, content=注重临床,必须要有临床数据,纯动物的不行。虽然是子刊,但文章的应用价值比Nature还要高,可信度也要高。是CNS里面最好的子刊了,发一篇这个不比CNS差,国内发nature medicine比CNS还难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Jan 15 10:45:56 CST 2021, time=2021-01-15, status=1, ipAttribution=)]
    2021-03-21 guolihuihelan_91618321

    想中一篇, 有没有什么捷径?

    9

    展开9条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2144371, encodeId=279421443e14d, content=审稿速度:1.0<br>偏重的研究方向:临床医学<br>经验分享:4个月AIP, 6个月正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a0e5414334, createdName=ms4000001950564800, createdTime=Fri Jun 23 13:31:24 CST 2023, time=2023-06-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=538081, encodeId=e6c95380814a, content=我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=885, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baab2077197, createdName=1581f162d2m, createdTime=Fri Jun 16 00:00:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949968, encodeId=750294996859, content=想中一篇, 有没有什么捷径?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Sun Mar 21 20:18:57 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070171, encodeId=ad8d10e01712a, content=投稿命中率:5.0<br>偏重的研究方向:Medicine;医学<br>经验分享:终于发了一篇~~脑卒中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Sun Nov 14 15:33:50 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095494, encodeId=4373109549485, content=引言需要写什么内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095493, encodeId=9aef1095493ba, content=引言一般分几段?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=549, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566699, encodeId=41ff56669936, content=我以第一作者身份发过5篇,审稿三天。ps:在梦里。<span class="quote">158****9100暂无昵称 2017-06-16 发表::<br>SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span><span class="quote">158****9100 2017-06-16 00:00:00 发表:<br>我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span>, beContent=158****9100暂无昵称 2017-06-16 发表:: SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Tue Feb 12 00:00:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860086, encodeId=ab9e8600864a, content=医学权威期刊,很幸运最近接收了一篇,祝好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=774, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88545414070, createdName=ms6126899454860855, createdTime=Fri May 01 18:24:26 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558775, encodeId=33dc558e75a1, content=和cancer cell一样都是魔王级受虐刊物 要求故事完整 论据充分 并不需和正刊一样的新颖性 即便如此 还是很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1063, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 20:17:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916839, encodeId=2dda91683946, content=注重临床,必须要有临床数据,纯动物的不行。虽然是子刊,但文章的应用价值比Nature还要高,可信度也要高。是CNS里面最好的子刊了,发一篇这个不比CNS差,国内发nature medicine比CNS还难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Jan 15 10:45:56 CST 2021, time=2021-01-15, status=1, ipAttribution=)]
    2021-11-14 ms8000001327218017

    投稿命中率:5.0
    偏重的研究方向:Medicine;医学
    经验分享:终于发了一篇~~脑卒中

    2

    展开2条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2144371, encodeId=279421443e14d, content=审稿速度:1.0<br>偏重的研究方向:临床医学<br>经验分享:4个月AIP, 6个月正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a0e5414334, createdName=ms4000001950564800, createdTime=Fri Jun 23 13:31:24 CST 2023, time=2023-06-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=538081, encodeId=e6c95380814a, content=我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=885, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baab2077197, createdName=1581f162d2m, createdTime=Fri Jun 16 00:00:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949968, encodeId=750294996859, content=想中一篇, 有没有什么捷径?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Sun Mar 21 20:18:57 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070171, encodeId=ad8d10e01712a, content=投稿命中率:5.0<br>偏重的研究方向:Medicine;医学<br>经验分享:终于发了一篇~~脑卒中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Sun Nov 14 15:33:50 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095494, encodeId=4373109549485, content=引言需要写什么内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095493, encodeId=9aef1095493ba, content=引言一般分几段?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=549, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566699, encodeId=41ff56669936, content=我以第一作者身份发过5篇,审稿三天。ps:在梦里。<span class="quote">158****9100暂无昵称 2017-06-16 发表::<br>SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span><span class="quote">158****9100 2017-06-16 00:00:00 发表:<br>我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span>, beContent=158****9100暂无昵称 2017-06-16 发表:: SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Tue Feb 12 00:00:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860086, encodeId=ab9e8600864a, content=医学权威期刊,很幸运最近接收了一篇,祝好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=774, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88545414070, createdName=ms6126899454860855, createdTime=Fri May 01 18:24:26 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558775, encodeId=33dc558e75a1, content=和cancer cell一样都是魔王级受虐刊物 要求故事完整 论据充分 并不需和正刊一样的新颖性 即便如此 还是很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1063, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 20:17:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916839, encodeId=2dda91683946, content=注重临床,必须要有临床数据,纯动物的不行。虽然是子刊,但文章的应用价值比Nature还要高,可信度也要高。是CNS里面最好的子刊了,发一篇这个不比CNS差,国内发nature medicine比CNS还难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Jan 15 10:45:56 CST 2021, time=2021-01-15, status=1, ipAttribution=)]
    2021-12-29 学医的彭于晏

    引言需要写什么内容?

    1

    展开1条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2144371, encodeId=279421443e14d, content=审稿速度:1.0<br>偏重的研究方向:临床医学<br>经验分享:4个月AIP, 6个月正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a0e5414334, createdName=ms4000001950564800, createdTime=Fri Jun 23 13:31:24 CST 2023, time=2023-06-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=538081, encodeId=e6c95380814a, content=我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=885, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baab2077197, createdName=1581f162d2m, createdTime=Fri Jun 16 00:00:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949968, encodeId=750294996859, content=想中一篇, 有没有什么捷径?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Sun Mar 21 20:18:57 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070171, encodeId=ad8d10e01712a, content=投稿命中率:5.0<br>偏重的研究方向:Medicine;医学<br>经验分享:终于发了一篇~~脑卒中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Sun Nov 14 15:33:50 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095494, encodeId=4373109549485, content=引言需要写什么内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095493, encodeId=9aef1095493ba, content=引言一般分几段?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=549, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566699, encodeId=41ff56669936, content=我以第一作者身份发过5篇,审稿三天。ps:在梦里。<span class="quote">158****9100暂无昵称 2017-06-16 发表::<br>SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span><span class="quote">158****9100 2017-06-16 00:00:00 发表:<br>我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span>, beContent=158****9100暂无昵称 2017-06-16 发表:: SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Tue Feb 12 00:00:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860086, encodeId=ab9e8600864a, content=医学权威期刊,很幸运最近接收了一篇,祝好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=774, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88545414070, createdName=ms6126899454860855, createdTime=Fri May 01 18:24:26 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558775, encodeId=33dc558e75a1, content=和cancer cell一样都是魔王级受虐刊物 要求故事完整 论据充分 并不需和正刊一样的新颖性 即便如此 还是很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1063, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 20:17:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916839, encodeId=2dda91683946, content=注重临床,必须要有临床数据,纯动物的不行。虽然是子刊,但文章的应用价值比Nature还要高,可信度也要高。是CNS里面最好的子刊了,发一篇这个不比CNS差,国内发nature medicine比CNS还难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Jan 15 10:45:56 CST 2021, time=2021-01-15, status=1, ipAttribution=)]
    2021-12-28 msSSSSSD

    引言一般分几段?

    1

    展开1条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2144371, encodeId=279421443e14d, content=审稿速度:1.0<br>偏重的研究方向:临床医学<br>经验分享:4个月AIP, 6个月正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a0e5414334, createdName=ms4000001950564800, createdTime=Fri Jun 23 13:31:24 CST 2023, time=2023-06-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=538081, encodeId=e6c95380814a, content=我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=885, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baab2077197, createdName=1581f162d2m, createdTime=Fri Jun 16 00:00:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949968, encodeId=750294996859, content=想中一篇, 有没有什么捷径?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Sun Mar 21 20:18:57 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070171, encodeId=ad8d10e01712a, content=投稿命中率:5.0<br>偏重的研究方向:Medicine;医学<br>经验分享:终于发了一篇~~脑卒中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Sun Nov 14 15:33:50 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095494, encodeId=4373109549485, content=引言需要写什么内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095493, encodeId=9aef1095493ba, content=引言一般分几段?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=549, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566699, encodeId=41ff56669936, content=我以第一作者身份发过5篇,审稿三天。ps:在梦里。<span class="quote">158****9100暂无昵称 2017-06-16 发表::<br>SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span><span class="quote">158****9100 2017-06-16 00:00:00 发表:<br>我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span>, beContent=158****9100暂无昵称 2017-06-16 发表:: SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Tue Feb 12 00:00:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860086, encodeId=ab9e8600864a, content=医学权威期刊,很幸运最近接收了一篇,祝好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=774, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88545414070, createdName=ms6126899454860855, createdTime=Fri May 01 18:24:26 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558775, encodeId=33dc558e75a1, content=和cancer cell一样都是魔王级受虐刊物 要求故事完整 论据充分 并不需和正刊一样的新颖性 即便如此 还是很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1063, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 20:17:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916839, encodeId=2dda91683946, content=注重临床,必须要有临床数据,纯动物的不行。虽然是子刊,但文章的应用价值比Nature还要高,可信度也要高。是CNS里面最好的子刊了,发一篇这个不比CNS差,国内发nature medicine比CNS还难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Jan 15 10:45:56 CST 2021, time=2021-01-15, status=1, ipAttribution=)]
    2019-02-12 不忘初心方为始终

    我以第一作者身份发过5篇,审稿三天。ps:在梦里。158****9100暂无昵称 2017-06-16 发表::
    SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长
    158****9100 2017-06-16 00:00:00 发表:
    我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长

    158****9100暂无昵称 2017-06-16 发表:: SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长

    1

    展开1条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2144371, encodeId=279421443e14d, content=审稿速度:1.0<br>偏重的研究方向:临床医学<br>经验分享:4个月AIP, 6个月正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a0e5414334, createdName=ms4000001950564800, createdTime=Fri Jun 23 13:31:24 CST 2023, time=2023-06-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=538081, encodeId=e6c95380814a, content=我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=885, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baab2077197, createdName=1581f162d2m, createdTime=Fri Jun 16 00:00:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949968, encodeId=750294996859, content=想中一篇, 有没有什么捷径?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Sun Mar 21 20:18:57 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070171, encodeId=ad8d10e01712a, content=投稿命中率:5.0<br>偏重的研究方向:Medicine;医学<br>经验分享:终于发了一篇~~脑卒中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Sun Nov 14 15:33:50 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095494, encodeId=4373109549485, content=引言需要写什么内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095493, encodeId=9aef1095493ba, content=引言一般分几段?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=549, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566699, encodeId=41ff56669936, content=我以第一作者身份发过5篇,审稿三天。ps:在梦里。<span class="quote">158****9100暂无昵称 2017-06-16 发表::<br>SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span><span class="quote">158****9100 2017-06-16 00:00:00 发表:<br>我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span>, beContent=158****9100暂无昵称 2017-06-16 发表:: SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Tue Feb 12 00:00:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860086, encodeId=ab9e8600864a, content=医学权威期刊,很幸运最近接收了一篇,祝好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=774, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88545414070, createdName=ms6126899454860855, createdTime=Fri May 01 18:24:26 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558775, encodeId=33dc558e75a1, content=和cancer cell一样都是魔王级受虐刊物 要求故事完整 论据充分 并不需和正刊一样的新颖性 即便如此 还是很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1063, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 20:17:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916839, encodeId=2dda91683946, content=注重临床,必须要有临床数据,纯动物的不行。虽然是子刊,但文章的应用价值比Nature还要高,可信度也要高。是CNS里面最好的子刊了,发一篇这个不比CNS差,国内发nature medicine比CNS还难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Jan 15 10:45:56 CST 2021, time=2021-01-15, status=1, ipAttribution=)]
    2020-05-01 ms6126899454860855

    医学权威期刊,很幸运最近接收了一篇,祝好运

    1

    展开1条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2144371, encodeId=279421443e14d, content=审稿速度:1.0<br>偏重的研究方向:临床医学<br>经验分享:4个月AIP, 6个月正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a0e5414334, createdName=ms4000001950564800, createdTime=Fri Jun 23 13:31:24 CST 2023, time=2023-06-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=538081, encodeId=e6c95380814a, content=我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=885, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baab2077197, createdName=1581f162d2m, createdTime=Fri Jun 16 00:00:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949968, encodeId=750294996859, content=想中一篇, 有没有什么捷径?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Sun Mar 21 20:18:57 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070171, encodeId=ad8d10e01712a, content=投稿命中率:5.0<br>偏重的研究方向:Medicine;医学<br>经验分享:终于发了一篇~~脑卒中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Sun Nov 14 15:33:50 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095494, encodeId=4373109549485, content=引言需要写什么内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095493, encodeId=9aef1095493ba, content=引言一般分几段?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=549, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566699, encodeId=41ff56669936, content=我以第一作者身份发过5篇,审稿三天。ps:在梦里。<span class="quote">158****9100暂无昵称 2017-06-16 发表::<br>SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span><span class="quote">158****9100 2017-06-16 00:00:00 发表:<br>我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span>, beContent=158****9100暂无昵称 2017-06-16 发表:: SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Tue Feb 12 00:00:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860086, encodeId=ab9e8600864a, content=医学权威期刊,很幸运最近接收了一篇,祝好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=774, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88545414070, createdName=ms6126899454860855, createdTime=Fri May 01 18:24:26 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558775, encodeId=33dc558e75a1, content=和cancer cell一样都是魔王级受虐刊物 要求故事完整 论据充分 并不需和正刊一样的新颖性 即便如此 还是很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1063, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 20:17:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916839, encodeId=2dda91683946, content=注重临床,必须要有临床数据,纯动物的不行。虽然是子刊,但文章的应用价值比Nature还要高,可信度也要高。是CNS里面最好的子刊了,发一篇这个不比CNS差,国内发nature medicine比CNS还难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Jan 15 10:45:56 CST 2021, time=2021-01-15, status=1, ipAttribution=)]
    2018-07-02 bigapple001

    和cancer cell一样都是魔王级受虐刊物 要求故事完整 论据充分 并不需和正刊一样的新颖性 即便如此 还是很难

    2

    展开2条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2144371, encodeId=279421443e14d, content=审稿速度:1.0<br>偏重的研究方向:临床医学<br>经验分享:4个月AIP, 6个月正式接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=112, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0a0e5414334, createdName=ms4000001950564800, createdTime=Fri Jun 23 13:31:24 CST 2023, time=2023-06-23, status=1, ipAttribution=上海), GetPortalCommentsPageByObjectIdResponse(id=538081, encodeId=e6c95380814a, content=我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=885, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=baab2077197, createdName=1581f162d2m, createdTime=Fri Jun 16 00:00:00 CST 2017, time=2017-06-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=949968, encodeId=750294996859, content=想中一篇, 有没有什么捷径?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=4, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=45fa2432519, createdName=guolihuihelan_91618321, createdTime=Sun Mar 21 20:18:57 CST 2021, time=2021-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1070171, encodeId=ad8d10e01712a, content=投稿命中率:5.0<br>偏重的研究方向:Medicine;医学<br>经验分享:终于发了一篇~~脑卒中, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=609, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=cee75506658, createdName=ms8000001327218017, createdTime=Sun Nov 14 15:33:50 CST 2021, time=2021-11-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095494, encodeId=4373109549485, content=引言需要写什么内容?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:50 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1095493, encodeId=9aef1095493ba, content=引言一般分几段?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=549, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Tue Dec 28 14:52:50 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566699, encodeId=41ff56669936, content=我以第一作者身份发过5篇,审稿三天。ps:在梦里。<span class="quote">158****9100暂无昵称 2017-06-16 发表::<br>SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span><span class="quote">158****9100 2017-06-16 00:00:00 发表:<br>我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长</span>, beContent=158****9100暂无昵称 2017-06-16 发表:: SCI(2015):30.357 SCI(2014):27.363 我以一作身份发过两篇,都是肠道菌群相关的,审稿时间相对较长, objectType=tool_impact_factor, channel=null, level=null, likeNumber=901, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221024/94d4daccb86c4ca5b3c0bd72b3f07175/6ebb64a27cac4d6d816782ef7ba100b6.jpg, createdBy=f0842413356, createdName=不忘初心方为始终, createdTime=Tue Feb 12 00:00:00 CST 2019, time=2019-02-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=860086, encodeId=ab9e8600864a, content=医学权威期刊,很幸运最近接收了一篇,祝好运 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=774, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=88545414070, createdName=ms6126899454860855, createdTime=Fri May 01 18:24:26 CST 2020, time=2020-05-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558775, encodeId=33dc558e75a1, content=和cancer cell一样都是魔王级受虐刊物 要求故事完整 论据充分 并不需和正刊一样的新颖性 即便如此 还是很难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1063, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f8eb1668018, createdName=bigapple001, createdTime=Mon Jul 02 20:17:00 CST 2018, time=2018-07-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=916839, encodeId=2dda91683946, content=注重临床,必须要有临床数据,纯动物的不行。虽然是子刊,但文章的应用价值比Nature还要高,可信度也要高。是CNS里面最好的子刊了,发一篇这个不比CNS差,国内发nature medicine比CNS还难, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=702, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211026/130f1b4c56624fe29a27048308d1902f/4f51757ef2084492b45315805618ca56.jpg, createdBy=832b2252477, createdName=张晓梅-Xiaomei Zhang, createdTime=Fri Jan 15 10:45:56 CST 2021, time=2021-01-15, status=1, ipAttribution=)]
    2021-01-15 张晓梅-Xiaomei Zhang

    注重临床,必须要有临床数据,纯动物的不行。虽然是子刊,但文章的应用价值比Nature还要高,可信度也要高。是CNS里面最好的子刊了,发一篇这个不比CNS差,国内发nature medicine比CNS还难

    3

    展开3条回复
共61条页码: 1/7页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分